If you’re looking for MS care in Massachusetts, you have access to a concentrated network of specialized centers across the state, including programs in Boston and regional hubs like Sturdy Memorial Hospital. Use these options to compare services, provider experience, and location so you can find the center that best fits your needs.
15 MS treatment centers47 active clinical trials118 providers with Medicare prescribing dataTop centers include Brigham, Lahey, Mass General
Center types in Massachusetts
Dedicated MS Practice (6)
Academic MS Center (4)
Regional Neurology Group (3)
Community Hospital Program (2)
Filter by type:
40% of MS centers in Massachusetts are classified as Dedicated MS Practice facilities.
Centers with Most Active Trials in Massachusetts
Ranked by active clinical trial count from ClinicalTrials.gov. Not a quality ranking.
2. Brigham Multiple Sclerosis Center10 trials
Largest Care Teams in Massachusetts
1. Brigham Multiple Sclerosis Center30 providers
2. Massachusetts General Hospital MS Clinic22 providers
3. UMass Memorial Medical Center MS Clinic18 providers
MS Care by City
Active MS clinical trials in Massachusetts
See all 55 MS trials in Massachusetts →ActivePhase 3
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
Hoffmann-La Roche
Boston · Worcester
ActivePhase 4
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Novartis Pharmaceuticals
Worcester
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Boston
ActivePhase 4
Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals
Brookline
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
Wellesley
Active
A Novel Wearable Digital Biomarker for Detecting Changes in Multiple Sclerosis (MS) Condition
Celestra Health Systems
Boston
ActivePhase 3
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Foxborough
ActivePhase 3
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
Wellesley Hills










